Copyright © 2001 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letter to the Editor
Lipoprotein (a) and thrombogenesis in left ventricular dysfunction
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birimingham, U.K.
References
- Rehnqvist N. Cell adhesion molecules, simvastatin and hormone replacement therapy, in coronary artery disease. Eur Heart J. 2000;21:963964
[Free Full Text] - Scott J. Lipoprotein (a). Br Med J. 1991;303:663664[ISI][Medline]
- Igarashi Y, Yamaura M, Ito M. Elevated serum lipoprotein (a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J. 1998;136:965971[CrossRef][ISI][Medline]
- Lip GYH, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol. 1999;33:14241426
[Free Full Text] - Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein (a) phenotypes, Lp(a) concentrations and plasma lipid levels in relation to coronary artery disease in a Chinese population: evidence for the role of the apo(a) gene in coronary artery disease. J Clin Invest. 1992;89:10401046[ISI][Medline]
- Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM. Relationship of plasma lipoprotein Lp(a) levels to race and apolipoprotein B. Arteriosclerosis. 1985;5:265271
[Abstract/Free Full Text] - Scanu AM. Lipoprotein (a). A genetic risk factor for premature coronary heart disease. JAMA. 1992;267:33263329[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||